Evidence map›Paper›PMID 34984467›Full record

ArticleNeuro-oncology2022

The scaffolding protein DLG5 promotes glioblastoma growth by controlling Sonic Hedgehog signaling in tumor stem cells.

Somanath Kundu, Mohan S Nandhu, Sharon L Longo, John A Longo, Shawn Rai, Lawrence S Chin, Timothy E Richardson, Mariano S Viapiano

Open access · bronzeAbstract read
In one paragraph

Article in Neuro-oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Somanath KunduDepartment of Neuroscience & Physiology, SUNY Upstate Medical University, Syracuse, New York, USA.
Mohan S NandhuDepartment of Neuroscience & Physiology, SUNY Upstate Medical University, Syracuse, New York, USA.
Sharon L LongoDepartment of Neurosurgery, SUNY Upstate Medical University, Syracuse, New York, USA.
John A LongoDepartment of Neuroscience & Physiology, SUNY Upstate Medical University, Syracuse, New York, USA.
Shawn RaiDepartment of Neurosurgery, SUNY Upstate Medical University, Syracuse, New York, USA.
Lawrence S ChinDepartment of Neurosurgery, SUNY Upstate Medical University, Syracuse, New York, USA.
Timothy E RichardsonDepartment of Pathology, University of Texas Health Science Center, San Antonio, Texas, USA.
Mariano S ViapianoDepartment of Neurosurgery, SUNY Upstate Medical University, Syracuse, New York, USA.ORCID 0000-0002-8756-388X
SUNY Upstate Medical University · USThe University of Texas Health Science Center at San Antonio · US

Funding

South Texas Alzheimer's Disease Research CenterP30AG066546 · NIA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Mohamad Habes · 2021 to 2026
$24.0M
Targeting cell polarity to disrupt the interaction of glioblastomas with the neural environmentR21NS106537 · NINDS · UPSTATE MEDICAL UNIVERSITY · PI VIAPIANO, MARIANO SEBASTIAN · 2019 to 2020
$446k
NIA NIH HHS P30 AG066546NINDS NIH HHS R21 NS106537
6 · The paper itself

Abstract

backgroundTumor invasion, a hallmark of malignant gliomas, involves reorganization of cell polarity and changes in the expression and distribution of scaffolding proteins associated with polarity complexes. The scaffolding proteins of the DLG family are usually downregulated in invasive tumors and regarded as tumor suppressors. Despite their important role in regulating neurodevelopmental signaling, the expression and functions of DLG proteins have remained almost entirely unexplored in malignant gliomas.

methodsWestern blot, immunohistochemistry, and analysis of gene expression were used to quantify DLG members in glioma specimens and cancer datasets. Over-expression and knockdown of DLG5, the highest-expressed DLG member in glioblastoma, were used to investigate its effects on tumor stem cells and tumor growth. qRT-PCR, Western blotting, and co-precipitation assays were used to investigate DLG5 signaling mechanisms.

resultsDLG5 was upregulated in malignant gliomas compared to other solid tumors, being the predominant DLG member in all glioblastoma molecular subtypes. DLG5 promoted glioblastoma stem cell invasion, viability, and self-renewal. Knockdown of this protein in vivo disrupted tumor formation and extended survival. At the molecular level, DLG5 regulated Sonic Hedgehog (Shh) signaling, making DLG5-deficient cells insensitive to Shh ligand. Loss of DLG5 increased the proteasomal degradation of Gli1, underlying the loss of Shh signaling and tumor stem cell sensitization.

conclusionsThe high expression and pro-tumoral functions of DLG5 in glioblastoma, including its dominant regulation of Shh signaling in tumor stem cells, reveal a novel role for this protein that is strikingly different from its proposed tumor-suppressor role in other solid tumors.

Indexed as

GlioblastomaGliomaHedgehog ProteinsMembrane ProteinsTumor Suppressor ProteinsCell Line, TumorGene Expression Regulation, NeoplasticHumansNeoplastic Stem CellsTranscription FactorsZinc Finger Protein GLI1DLG5 protein, humanHedgehog ProteinsMembrane ProteinsSHH protein, humanTranscription FactorsTumor Suppressor ProteinsZinc Finger Protein GLI1glioma invasionGLI signalingscaffold proteinsShh signalingtumor stem cells

Identifiers

PMID34984467
PMCPMC9340653
OpenAlexW4205150871

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.